Product Reports Resources Pricing Login Book a demo

PharmaFluidics

Biotech & Life Sciences · Ghent, Belgium · Founded 2010

Micro-chip based columns for analytical liquid chromatography MoreLess

PharmaFluidics was a Belgian company that developed and manufactured micro-chip-based chromatography columns for the life sciences industry. Founded in 2010 as a spin-off from the Vrije Universiteit Brussel (VUB) by Paul Jacobs and Gert Desmet, the company was established to commercialize a novel approach to liquid chromatography (LC). The founders combined expertise from analytical chromatography and semiconductor manufacturing to create their signature product, the micro Pillar Array Column, or µPAC™.

The company's core technology involved using lithographic etching, a technique from the semiconductor industry, to create a perfectly ordered separation bed on a silicon chip. This design of freestanding pillars in an array contrasted with conventional LC columns that use randomly packed beads. The µPAC™ columns offered higher resolution, sensitivity, and reproducibility, allowing for the identification of more compounds in complex biological samples like proteome digests, biopsies, and biopharmaceutical actives. The technology's benefits included improved data productivity and robustness, particularly for analyzing small sample volumes.

PharmaFluidics targeted biotechnology and pharmaceutical companies involved in biomarker research, proteomics, and drug research and development. The business model focused on manufacturing and selling these proprietary µPAC™ cartridges, which were compatible with standard nano-LC and capillary LC systems. The company engaged in partnerships and collaborations to expand its market reach, including a significant agreement with Thermo Fisher Scientific in 2018 to create an integrated front-end platform for mass spectrometry instruments. After several funding rounds, PharmaFluidics was acquired by Thermo Fisher Scientific on November 1, 2021. The acquisition was intended to complement Thermo Fisher's existing chromatography solutions and extend its analytical capabilities for biopharma customers.

Keywords: liquid chromatography, micro-chip columns, pillar array technology, proteomics, biomarker discovery, biopharmaceutical analysis, mass spectrometry, analytical instruments, µPAC, separations science, nano-LC, capillary LC, drug research, diagnostics, lab-on-a-chip, microfluidics, Thermo Fisher Scientific, life sciences tools, analytical separation, chemical engineering

Talent graph

PharmaFluidics's talent

Book a demo to see the people
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on PharmaFluidics's cap table

Sourced from Dealroom's funding and investor records.

Series A 8 investors entered at this stage
Qbic Fund
Innovation Fund | Brussels
PMV
Volksvermogen
Seido Capital
SFPIM
Heran
RMM

Global footprint

Where PharmaFluidics has talent and traffic

Workforce by country
🇧🇪 Belgium · Ghent HQ
Book a demo for the full country breakdown

Market sentiment

What the market is saying about PharmaFluidics

An AI-synthesized read of the highest-engagement posts about PharmaFluidics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See PharmaFluidics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.